TussilagononeCAS# 110042-38-1 |
Quality Control & MSDS
3D structure
Package In Stock
Number of papers citing our products
| Cas No. | 110042-38-1 | SDF | Download SDF |
| PubChem ID | 13919188 | Appearance | Powder |
| Formula | C21H30O3 | M.Wt | 330.5 |
| Type of Compound | N/A | Storage | Desiccate at -20°C |
| Solubility | Soluble in Chloroform,Dichloromethane,Ethyl Acetate,DMSO,Acetone,etc. | ||
| Chemical Name | [(1Z,3aR,5R,7S,7aS)-1-ethylidene-4-methylidene-2-oxo-7-propan-2-yl-3,3a,5,6,7,7a-hexahydroinden-5-yl] (E)-3-methylpent-2-enoate | ||
| SMILES | CCC(=CC(=O)OC1CC(C2C(C1=C)CC(=O)C2=CC)C(C)C)C | ||
| Standard InChIKey | ORVROQPLYIDWBD-QWCDRRILSA-N | ||
| Standard InChI | InChI=1S/C21H30O3/c1-7-13(5)9-20(23)24-19-11-16(12(3)4)21-15(8-2)18(22)10-17(21)14(19)6/h8-9,12,16-17,19,21H,6-7,10-11H2,1-5H3/b13-9+,15-8+/t16-,17-,19+,21-/m0/s1 | ||
| General tips | For obtaining a higher solubility , please warm the tube at 37 ℃ and shake it in the ultrasonic bath for a while.Stock solution can be stored below -20℃ for several months. We recommend that you prepare and use the solution on the same day. However, if the test schedule requires, the stock solutions can be prepared in advance, and the stock solution must be sealed and stored below -20℃. In general, the stock solution can be kept for several months. Before use, we recommend that you leave the vial at room temperature for at least an hour before opening it. |
||
| About Packaging | 1. The packaging of the product may be reversed during transportation, cause the high purity compounds to adhere to the neck or cap of the vial.Take the vail out of its packaging and shake gently until the compounds fall to the bottom of the vial. 2. For liquid products, please centrifuge at 500xg to gather the liquid to the bottom of the vial. 3. Try to avoid loss or contamination during the experiment. |
||
| Shipping Condition | Packaging according to customer requirements(5mg, 10mg, 20mg and more). Ship via FedEx, DHL, UPS, EMS or other couriers with RT, or blue ice upon request. | ||
Tussilagonone Dilution Calculator
Tussilagonone Molarity Calculator
| 1 mg | 5 mg | 10 mg | 20 mg | 25 mg | |
| 1 mM | 3.0257 mL | 15.1286 mL | 30.2572 mL | 60.5144 mL | 75.643 mL |
| 5 mM | 0.6051 mL | 3.0257 mL | 6.0514 mL | 12.1029 mL | 15.1286 mL |
| 10 mM | 0.3026 mL | 1.5129 mL | 3.0257 mL | 6.0514 mL | 7.5643 mL |
| 50 mM | 0.0605 mL | 0.3026 mL | 0.6051 mL | 1.2103 mL | 1.5129 mL |
| 100 mM | 0.0303 mL | 0.1513 mL | 0.3026 mL | 0.6051 mL | 0.7564 mL |
| * Note: If you are in the process of experiment, it's necessary to make the dilution ratios of the samples. The dilution data above is only for reference. Normally, it's can get a better solubility within lower of Concentrations. | |||||
Calcutta University
University of Minnesota
University of Maryland School of Medicine
University of Illinois at Chicago
The Ohio State University
University of Zurich
Harvard University
Colorado State University
Auburn University
Yale University
Worcester Polytechnic Institute
Washington State University
Stanford University
University of Leipzig
Universidade da Beira Interior
The Institute of Cancer Research
Heidelberg University
University of Amsterdam
University of Auckland
TsingHua University
The University of Michigan
Miami University
DRURY University
Jilin University
Fudan University
Wuhan University
Sun Yat-sen University
Universite de Paris
Deemed University
Auckland University
The University of Tokyo
Korea University
- Taurohyodeoxycholic Acid Sodium Salt
Catalog No.:BCC8363
CAS No.:110026-03-4
- 8-O-Ethylyunaconitine
Catalog No.:BCN6260
CAS No.:110011-77-3
- Sorbic acid
Catalog No.:BCN2218
CAS No.:110-44-1
- Fumaric acid
Catalog No.:BCN5989
CAS No.:110-17-8
- Maleic acid
Catalog No.:BCN8426
CAS No.:110-16-7
- Succinic acid
Catalog No.:BCN5890
CAS No.:110-15-6
- ITD 1
Catalog No.:BCC6409
CAS No.:1099644-42-4
- Kifunensine
Catalog No.:BCC7601
CAS No.:109944-15-2
- Sodium prasterone sulfate
Catalog No.:BCC9149
CAS No.:1099-87-2
- Granisetron
Catalog No.:BCC1601
CAS No.:109889-09-0
- CGS 9343B
Catalog No.:BCC7303
CAS No.:109826-27-9
- Kaempferol 5,7,4'-trimethyl ether
Catalog No.:BCN6587
CAS No.:1098-92-6
- Calpain Inhibitor I, ALLN
Catalog No.:BCC1233
CAS No.:110044-82-1
- Strophantin K (mixture)
Catalog No.:BCC8256
CAS No.:11005-63-3
- 7-Hydroxy-3-(4-hydroxybenzylidene)chroman-4-one
Catalog No.:BCN1624
CAS No.:110064-50-1
- 12-Epinapelline
Catalog No.:BCN2800
CAS No.:110064-71-6
- Plerixafor (AMD3100)
Catalog No.:BCC1158
CAS No.:110078-46-1
- des-His1-[Glu9]-Glucagon (1-29) amide
Catalog No.:BCC5885
CAS No.:110084-95-2
- Ascomycin
Catalog No.:BCN8286
CAS No.:11011-38-4
- Indoximod (NLG-8189)
Catalog No.:BCC5584
CAS No.:110117-83-4
- Methyl hesperidin
Catalog No.:BCN6341
CAS No.:11013-97-1
- 4-Galloylquinic acid
Catalog No.:BCN3733
CAS No.:110170-37-1
- Ouabain Octahydrate
Catalog No.:BCC5211
CAS No.:11018-89-6
- JZL184
Catalog No.:BCC4790
CAS No.:1101854-58-3
Tussilagonone-induced Nrf2 pathway activation protects HepG2 cells from oxidative injury.[Pubmed:28733231]
Food Chem Toxicol. 2017 Oct;108(Pt A):120-127.
Tussilagonone is a compound derived from the medicinal plant Tussilago farfara L., which is used as a traditional medicine for respiratory diseases, including asthma and pneumonia. Recent reports suggest that Tussilagonone exhibits anti-inflammatory effects; however, the scope of protective functions has not been elucidated yet. In this study, we demonstrate that Tussilagonone enhances cellular detoxification by increasing quinone reductase activity in Hepa1c1c7 cells. In addition, Tussilagonone decreased tert-butyl hydroperoxide(t-BHP)-induced ROS production and cell death, suggesting that it also acts as a potent antioxidant. To verify the molecular mechanism underlying Tussilagonone activity, we examined the expression of nuclear factor erythroid 2-related factor 2(Nrf2)-a transcription factor that regulates antioxidant protein expression-in HepG2 cells. Significantly, these results showed that Tussilagonone induces Nrf2 activation and nuclear accumulation, resulting in the upregulation of the detoxifying enzymes NAD(P)H quinone dehydrogenase 1(NQO1) and heme oxygenase-1(HO-1) that protect cells from oxidative stress. Further molecular analyses revealed that Tussilagonone-induced Nrf2 activation was mediated by ERK1/2 in HepG2 cells. Collectively, these data indicate that Tussilagonone attenuates t-BHP-induced ROS and activates quinone reductase activity via Nrf2 pathway activation and target gene expression, and thereby acts as an antioxidant that protects HepG2 cells from oxidative stress and associated damage.
